The disparity of cervical cancer in diverse populations

Gynecologic Oncology

Volumn 109, Issue 2 SUPPL., 2008, Pages

  Downs, Levi S ^a   Smith, Jennifer S ^b   Scarinci, Isabel ^c   Flowers, Lisa ^d   Parham, Groesbeck ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b IL   (United States)

^c University of Alabama at Birmingham   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cervical cancer; Disparity; Ethnicity; HPV

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COMORBIDITY; DISASTER; DISEASE ASSOCIATION; FOLLOW UP; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROPHYLAXIS; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

ETHNIC GROUPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; SOCIOECONOMIC FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 43149107665     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.01.003     Document Type: Article

References (79)

1. Ries L., Harkins D., Krapcho M., Mariotto A., Miller B., Feuer E., Clegg L., Eisner M., Horner M., Howlader N., Hayat M., Hankey B., and Edwards B. SEER Cancer Statistics Review, 1975-2004 (2007), National Cancer Institute, Bethesda, MD based on November 2005 SEER data submission, posted to the SEER web site
2. McCracken M., Olsen M., Chen M., Jemal A., Thun M., Cokkinides V., Deapen D., and Ward E. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57 (2007) 190-205
3. del Carmen M., Montz F., Bristow R., Bovicelli A., Cornelison T., and Trimble E. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol. Oncol. 75 (1999) 113-117
4. Gilliland F., Hunt W., and Key C. Trends in the survival of American Indian, Hispanic, and Non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994. Cancer 82 (1998) 1769-1783
5. Howe H., Wu X., Ries L., Cokkinides V., Ahmed F., Jemal A., Miller B., Williams M., Ward E., Wingo P., Ramirez A., and Edwards B. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107 (2006) 1711-1742
6. Patel D., Barnholtz-Sloan J., Patel M., Malone Jr. J., Chuba P., and Schwartz K. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol. Oncol. 97 (2005) 550-558
7. Saraiya M., Ahmed F., Krishnan S., Richards T., Unger E., and Lawson H. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet. Gynecol. 109 (2007) 360-370
8. Chu K., and Chu K. 1999-2001 cancer mortality rates for Asian and Pacific Islander ethnic groups with comparisons to their 1988-1992 rates. Cancer 104 (2005) 2989-2998
9. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
10. Seeff L., and McKenna M. Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996. Cancer Detect. Prev. 27 (2003) 203-208
11. Espey D., Paisano R., and Cobb N. Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990-2001. Cancer 103 (2005) 1045-1053
12. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer 120 (2007) 885-891
13. Santin A., Bellone S., Siegel E., Palmieri M., Thomas M., Cannon M., Kay H., Roman J., Burnett A., and Pecorelli S. Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am. J. Obstet. Gynecol. 192 (2005) 813-818
14. Healthy People 2010. US Department of Health and Human Services (2000)
15. DATA 2010. The Healthy People 2010 database. The Centers for Disease Control and Prevention (2007)
16. Saslow D., Runowicz C., Solomon D., Moscicki A., Smith R., Eyre H., and Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin. 52 (2002) 342-362
17. Spence A., Goggin P., and Franco E. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev. Med. 45 (2007) 93-106
18. Kagawa-Singer M., and Pourat N. Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives. Cancer 89 (2000) 696-705
19. De Alba I., Ngo-Metzger Q., Sweningson J., and Hubbell F. Pap smear use in California: are we closing the racial/ethnic gap?. Prev. Med. 40 (2005) 747-755
20. Swan J., Breen N., Burhansstipanov L., Satter D., Davis W., McNeel T., and Snipp C. Cancer screening and risk factor rates among American Indians. Am. J. Public Health 96 (2006) 340-350
21. Kandula N., Wen M., Jacobs E., and Lauderdale D. Low rates of colorectal, cervical, and breast cancer screening in Asian Americans compared with non-Hispanic whites: cultural influences or access to care?. Cancer 107 (2006) 184-192
22. Goel M., Wee C., McCarthy E., Davis R., Ngo-Metzger Q., and Phillips R. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J. Gen. Intern. Med. 18 (2003) 1028-1035
23. Akers A., Newmann S., and Smith J. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr. Probl. Cancer 31 (2007) 157-181
24. Engelstad L., Stewart S., Nguyen B., Bedeian K., Rubin M., Pasick R., and Hiatt R. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1015-1020
25. Cardin V., Grimes R., Jiang Z., Pomeroy N., Harrell L., and Cano P. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations. Public Health Rep. 116 (2001) 608-616
26. The Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program (2007)
27. Benard V., Lawson H., Eheman C., Anderson C., and Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet. Gynecol. 105 (2005) 1323-1328
28. Shavers V., and Brown M. Racial and ethnic disparities in the receipt of cancer treatment. J. Natl. Cancer Inst. 94 (2002) 334-357
29. Ell K., Vourlekis B., Muderspach L., Nissly J., Padgett D., Pineda D., Sarabia O., and Lee P. Abnormal cervical screen follow-up among low-income Latinas: Project SAFe. J. Womens Health Gend. Based Med. 11 (2002) 639-651
30. Coronado G., Thompson B., Koepsell T., Schwartz S., and McLerran D. Use of Pap test among Hispanics and non-Hispanic whites in a rural setting. Prev. Med. 38 (2004) 713-722
31. De Alba I., and Sweningson J. English proficiency and physicians' recommendation of Pap smears among Hispanics. Cancer Detect. Prev. 30 (2006) 292-296
32. Nguyen T., McPhee S., Nguyen T., Lam T., and Mock J. Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women. Am. J. Prev. Med. 23 (2002) 207-214
33. Rodriguez M., Ward L., and Perez-Stable E. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann. Fam. Med. 3 (2005) 235-241
34. Newmann S., and Garner E. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16 (2005) 63-70
35. McMullin J., De Alba I., Chavez L., and Hubbell F. Influence of beliefs about cervical cancer etiology on Pap smear use among Latina immigrants. Ethn. Health 10 (2005) 3-18
36. Taylor V., Schwartz S., Yasui Y., Burke N., Shu J., Lam D., and Jackson J. Pap testing among Vietnamese women: health care system and physician factors. J. Community Health 29 (2004) 437-450
37. Behbakht K., Lynch A., Teal S., Degeest K., and Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet. Gynecol 104 (2004) 1355-1361
38. Scarinci I., Beech B., Kovach K., and Bailey T. An examination of sociocultural factors associated with cervical cancer screening among low-income Latina immigrants of reproductive age. J. Immigr. Health 5 (2003) 119-128
39. Byrd T., Peterson S., Chavez R., and Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev. Med. 38 (2004) 192-197
40. Taylor V., Jackson J., Tu S., Yasui Y., Schwartz S., Kuniyuki A., Acorda E., Lin K., and Hislop G. Cervical cancer screening among Chinese Americans. Cancer Detect. Prev. 26 (2002) 139-145
41. del Carmen M., Findley M., Muzikansky A., Roche M., Verrill C., Horowitz N., and Seiden M. Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy. Gynecol. Oncol. 104 (2007) 70-76
42. Coughlin S., Breslau E., Thompson T., and Benard V. Physician recommendation for Papanicolaou testing among U.S. women, 2000. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1143-1148
43. Taylor V., Yasui Y., Burke N., Nguyen T., Acorda E., Thai H., Qu P., and Jackson J. Pap testing adherence among Vietnamese American women. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 613-619
44. Adams E., Breen N., and Joski P. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer 109 (2007) 348-358
45. Bazargan M., Bazargan S., Farooq M., and Baker R. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev. Med. 39 (2004) 465-473
46. Harlan L., Greene A., Clegg L., Mooney M., Stevens J., and Brown M. Insurance status and the use of guideline therapy in the treatment of selected cancers. J. Clin. Oncol. 23 (2005) 9079-9088
47. Schwartz K., Crossley-May H., Vigneau F., Brown K., and Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control 14 (2003) 761-766
48. Farley J., Hines J., Taylor R., Carlson J., Parker M., Kost E., Rogers S., Harrison T., Macri C., and Parham G. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 91 (2001) 869-873
49. Phillips K., Mayer M., and Aday L. Barriers to care among racial/ethnic groups under managed care. Health Aff. (Millwood) 19 (2000) 65-75
50. O'Malley A., and Forrest C. Beyond the examination room: primary care performance and the patient-physician relationship for low-income women. J. Gen. Intern. Med. 17 (2002) 66-74
51. Walboomers J., Jacobs M., Manos M., Bosch F., Kummer J., Shah K., Snijders P., Peto J., Meijer C., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
52. Friedman A., and Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ. Behav. 34 (2007) 471-485
53. Scarinci I.C., Garcés-Palacio I., and Partridge E.E. An examination of acceptability of HPV preventive vaccination among African American women and Latina immigrants. J Womens Health 16 8 (2007) 1224-1233
54. Risendal B., DeZapien J., Fowler B., Papenfuss M., and Giuliano A. Pap smear screening among urban Southwestern American Indian women. Prev. Med. 29 (1999) 510-518
55. Breitkopf C., Pearson H., and Breitkopf D. Poor knowledge regarding the Pap test among low-income women undergoing routine screening. Perspect. Sex Reprod. Health 37 (2005) 78-84
56. Yu E., Kim K., Chen E., and Brintnall R. Breast and cervical cancer screening among Chinese American women. Cancer Pract. 9 (2001) 81-91
57. Brewer N., and Fazekas K. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev. Med. 45 (2007) 107-114
58. Constatine N., and Jerman P. Acceptance of human papillomarvirus vaccination among Californian parents of daughters: a Representative Statewide Analysis. J. of Adolesc. Health 40 (2007) 108-115
59. Cates J., Brewer N., Fazekas K., Mitchell C., and Smith J. Race-related differences in knowledge and attitudes about HPV vaccination in the rural Southern United States. In: 17th ISSTDR World Congress (2007), Seattle, Washington
60. Population Estimates. The US Census Bureau (2007)
61. U.S. Census Bureau, 2004. U.S. interim projections by age, sex, race, and Hispanic Origin (2004)
62. US Census Bureau. Interim projections of the U.S. population by age, sex, race, and Hispanic Origin: summary methodology and assumptions (2004)
63. Ryerson A., Benard V., and Major A. The National Breast and Cervical Cancer Early Detection Program: 1991-2002 National Report (2005), The Centers for Disease Control and Prevention, Atlanta, GA
64. Fowler T., Steakley C., Garcia A., Kwok J., and Bennett L. Reducing disparities in the burden of cancer: the role of patient navigators. PLoS Med. 3 (2006) e193
65. Freeman H., and Vydelingum N. The role of the special populations networks program in eliminating cancer health disparities. Cancer 107 (2006) 1933-1935
66. Jackson F., Chu K., and Garcia R. Special Populations Networks-how this innovative community-based initiative affected minority and underserved research programs. Cancer 107 (2006) 1939-1944
67. Hansen L., Feigl P., Modiano M., Lopez J., Escobedo Sluder S., Moinpour C., Pauler D., and Meyskens F. An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study. Cancer Nurs. 28 (2005) 47-53
68. Margolis K., Lurie N., McGovern P., Tyrrell M., and Slater J. Increasing breast and cervical cancer screening in low-income women. J. Gen. Intern. Med. 13 (1998) 515-521
69. Miller S., Siejak K., Schroeder C., Lerman C., Hernandez E., and Helm C. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. J. Natl. Cancer Inst. 89 (1997) 703-708
70. Mock J., McPhee S., Nguyen T., Wong C., Doan H., Lai K., Nguyen K., Nguyen T., and Bui-Tong N. Effective lay health worker outreach and media-based education for promoting cervical cancer screening among Vietnamese American women. Am. J. Public Health (2007)
71. Taylor V., Hislop T., Jackson J., Tu S., Yasui Y., Schwartz S., Teh C., Kuniyuki A., Acorda E., Marchand A., and Thompson B. A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J. Natl. Cancer Inst. 94 (2002) 670-677
72. Wasserman M., Bender D., and Lee S.-Y. Use of preventive maternal and child health services by Latina Women. Med. Care Res. Rev. 64 (2007) 4-45
73. Smith J., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., and Clifford G. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121 (2007) 621-632
74. The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 356 (2007) 1915-1927
75. Harper D., Franco E., Wheeler C., Moscicki A., Romanowski B., Roteli-Martins C., Jenkins D., Schuind A., Costa Clemens S., and Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
76. Paavonen J., Jenkins D., Bosch F., Naud P., Salmerón J., Wheeler C., Chow S.-N., Apter D., Kitchener H., Castellsague X., de Carvalho N., Skinner S., Harper D., Hedrick J., Jaisamrarn U., Limson G., Dionne M., Quint W., Spiessens B., Peeters P., Struyf F., Wieting S., Lehtinen M., and Dubin G. for the HPV PATRICIA study group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet (2007)
77. Villa L., Costa R., Petta C., Andrade R., Paavonen J., Iversen O., Olsson S., Hoye J., Steinwall M., Riis-Johannessen G., Andersson-Ellstrom A., Elfgren K., Krogh G., Lehtinen M., Malm C., Tamms G., Giacoletti K., Lupinacci L., Railkar R., Taddeo F., Bryan J., Esser M., Sings H., Saah A., and Barr E. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br. J. Cancer 95 (2006) 1459-1466
78. Clegg L., Li F., Hankey B., Chu K., and Edwards B. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch. Intern. Med. 162 (2002) 1985-1993
79. The American Cancer Society. Cancer facts and figures, 2007 (2007), American Cancer Society, Atlanta